Dihydromyricetin is a dihydroflavonol flavonoid compound extracted from the traditional Chinese medicine Ampelopsis megalophyllaDiels et Gilg, which alleviates the symptoms of SLE by targeting inhibition of the mTOR autophagy-related signaling pathway and promoting the expression of LC3-II and Beclin-1 autophagy-related genes, thereby treating SLE (209). The gene discussed is MTOR; the disease is systemic lupus erythematosus.